Zeitschriftenartikel zum Thema „Acute exacerbation of interstitial lung diseases“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Acute exacerbation of interstitial lung diseases" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Aritonang, Rachel S., Fanny Fachrucha, Mia Elhidsi und Ginanjar Arum Desianti. „Oxygen Therapy in Exacerbation of Interstitial Lung Disease“. Respiratory Science 4, Nr. 3 (28.06.2024): 221–31. http://dx.doi.org/10.36497/respirsci.v4i3.129.
Der volle Inhalt der QuelleKolb, Martin, Benjamin Bondue, Alberto Pesci, Yasunari Miyazaki, Jin Woo Song, Nitin Y. Bhatt, John T. Huggins et al. „Acute exacerbations of progressive-fibrosing interstitial lung diseases“. European Respiratory Review 27, Nr. 150 (21.12.2018): 180071. http://dx.doi.org/10.1183/16000617.0071-2018.
Der volle Inhalt der QuelleAbo Elwafa, GihanS, NaglaaB Ahmed, AmanyA Abou Zeid und MaiA Abo Elhasab. „Noninvasive ventilation in acute exacerbation of interstitial lung diseases“. Egyptian Journal of Chest Diseases and Tuberculosis 72, Nr. 1 (2023): 99. http://dx.doi.org/10.4103/ecdt.ecdt_40_22.
Der volle Inhalt der QuelleDrakopanagiotakis, Fotios, Philipp Markart und Paschalis Steiropoulos. „Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers“. International Journal of Molecular Sciences 24, Nr. 12 (15.06.2023): 10196. http://dx.doi.org/10.3390/ijms241210196.
Der volle Inhalt der QuelleDrakopanagiotakis, Fotios, Ekaterina Krauss, Ira Michailidou, Vasileios Drosos, Stavros Anevlavis, Andreas Günther und Paschalis Steiropoulos. „Lung Cancer and Interstitial Lung Diseases“. Cancers 16, Nr. 16 (13.08.2024): 2837. http://dx.doi.org/10.3390/cancers16162837.
Der volle Inhalt der QuelleMatsunashi, Atsushi, Kazuma Nagata, Takeshi Morimoto und Keisuke Tomii. „Mechanical ventilation for acute exacerbation of fibrosing interstitial lung diseases“. Respiratory Investigation 61, Nr. 3 (Mai 2023): 306–13. http://dx.doi.org/10.1016/j.resinv.2023.01.008.
Der volle Inhalt der QuellePapanikolaou, Ilias C., Fotios Drakopanagiotakis und Vlasis S. Polychronopoulos. „Acute exacerbations of interstitial lung diseases“. Current Opinion in Pulmonary Medicine 16, Nr. 5 (September 2010): 480–86. http://dx.doi.org/10.1097/mcp.0b013e32833ae49d.
Der volle Inhalt der QuelleAkulkina, L. A., M. Yu Brovko, A. A. Schepalina, V. I. Sholomova, A. A. Kitbalian, A. S. Moiseev, P. P. Potapov und S. V. Moiseev. „A case of severe COVID-19 in a patient with progressive fibrosing interstitial lung disease“. PULMONOLOGIYA 32, Nr. 5 (21.09.2022): 763–69. http://dx.doi.org/10.18093/0869-0189-2022-32-5-763-769.
Der volle Inhalt der QuelleMagdy, Mohammed, Zainab Saaed, Emad Abd El-Aleem und Madyan Mahmoud. „Clinical and radiological signs of acute exacerbation of interstitial lung diseases“. Minia Journal of Medical Research 30, Nr. 3 (01.07.2019): 116–19. http://dx.doi.org/10.21608/mjmr.2022.221906.
Der volle Inhalt der QuelleIto, Yoko, Gen Tazaki, Yusuke Kondo, Genki Takahashi und Fumio Sakamaki. „Therapeutic effect of nintedanib on acute exacerbation of interstitial lung diseases“. Respiratory Medicine Case Reports 26 (2019): 317–20. http://dx.doi.org/10.1016/j.rmcr.2019.02.021.
Der volle Inhalt der QuelleSuzuki, Atsushi, Yasuhiro Kondoh, Kevin K. Brown, Takeshi Johkoh, Kensuke Kataoka, Junya Fukuoka, Tomoki Kimura et al. „Acute exacerbations of fibrotic interstitial lung diseases“. Respirology 25, Nr. 5 (19.08.2019): 525–34. http://dx.doi.org/10.1111/resp.13682.
Der volle Inhalt der QuelleAmati, Francesco, Anna Stainer, Veronica Polelli, Marco Mantero, Andrea Gramegna, Francesco Blasi und Stefano Aliberti. „Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review“. International Journal of Molecular Sciences 24, Nr. 9 (25.04.2023): 7849. http://dx.doi.org/10.3390/ijms24097849.
Der volle Inhalt der QuelleOn, Rintaro, Takemasa Matsumoto, Hisako Kushima, Ryosuke Hirano und Masaki Fujita. „Prevalence of viral infection in acute exacerbation of interstitial lung diseases in Japan“. Respiratory Investigation 58, Nr. 6 (November 2020): 473–78. http://dx.doi.org/10.1016/j.resinv.2020.06.006.
Der volle Inhalt der QuelleSalonen, Johanna, Minna Purokivi, Risto Bloigu und Riitta Kaarteenaho. „Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases“. BMJ Open Respiratory Research 7, Nr. 1 (April 2020): e000563. http://dx.doi.org/10.1136/bmjresp-2020-000563.
Der volle Inhalt der QuelleEnomoto, Noriyuki. „Pathological Roles of Pulmonary Cells in Acute Lung Injury: Lessons from Clinical Practice“. International Journal of Molecular Sciences 23, Nr. 23 (30.11.2022): 15027. http://dx.doi.org/10.3390/ijms232315027.
Der volle Inhalt der QuelleKaarteenaho, Riitta, und Vuokko L. Kinnula. „Diffuse Alveolar Damage: A Common Phenomenon in Progressive Interstitial Lung Disorders“. Pulmonary Medicine 2011 (2011): 1–10. http://dx.doi.org/10.1155/2011/531302.
Der volle Inhalt der QuelleSato, Toshihiko, Satoshi Teramukai, Haruhiko Kondo, Atsushi Watanabe, Masahito Ebina, Kazuma Kishi, Yoshitaka Fujii et al. „Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer“. Journal of Thoracic and Cardiovascular Surgery 147, Nr. 5 (Mai 2014): 1604–11. http://dx.doi.org/10.1016/j.jtcvs.2013.09.050.
Der volle Inhalt der QuelleAustin, Adam, Johnny Jaber, Katherine Fu, Lauran Zeineddine, Mohamed Omballi, George Mckenney, Ramsy Abdelghani, Diana Espinoza, David Becnel und Hiren J. Mehta. „Acute exacerbation of interstitial lung diseases and mortality post-cryobiopsy: a multicenter cohort study“. Journal of Thoracic Disease 16, Nr. 7 (Juli 2024): 4340–49. http://dx.doi.org/10.21037/jtd-24-270.
Der volle Inhalt der QuelleFurukawa, Hiroshi, Shomi Oka, Kota Shimada, Atsushi Hashimoto, Akiko Komiya, Toshihiro Matsui und Shigeto Tohma. „Role of Deleterious Rare Alleles for Acute-Onset Diffuse Interstitial Lung Disease in Collagen Diseases“. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 13 (Januar 2019): 117954841986644. http://dx.doi.org/10.1177/1179548419866443.
Der volle Inhalt der QuelleLarsen, Brandon T., und Thomas V. Colby. „Update for Pathologists on Idiopathic Interstitial Pneumonias“. Archives of Pathology & Laboratory Medicine 136, Nr. 10 (01.10.2012): 1234–41. http://dx.doi.org/10.5858/arpa.2012-0225-ra.
Der volle Inhalt der QuelleFaverio, Paola, Anna Stainer, Sara Conti, Fabiana Madotto, Federica De Giacomi, Matteo Della Zoppa, Ada Vancheri et al. „Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases“. Diagnostics 11, Nr. 9 (06.09.2021): 1623. http://dx.doi.org/10.3390/diagnostics11091623.
Der volle Inhalt der QuelleKimura, Toru, T. Nojiri, H. Hosoda, Y. Shintani, M. Inoue, M. Miyazato, M. Okumura und K. Kangawa. „P-227ESTABLISHMENT OF A NEW MOUSE MODEL FOR POSTOPERATIVE ACUTE EXACERBATION OF INTERSTITIAL LUNG DISEASES“. Interactive CardioVascular and Thoracic Surgery 21, suppl_1 (August 2015): S62. http://dx.doi.org/10.1093/icvts/ivv204.227.
Der volle Inhalt der QuelleSaraya, Takeshi, Hirokazu Kimura, Daisuke Kurai, Masaki Tamura, Yukari Ogawa, Sunao Mikura, Mitsuru Sada et al. „Clinical significance of respiratory virus detection in patients with acute exacerbation of interstitial lung diseases“. Respiratory Medicine 136 (März 2018): 88–92. http://dx.doi.org/10.1016/j.rmed.2018.02.003.
Der volle Inhalt der QuelleSalonen, Johanna, Hannu Vähänikkilä, Minna Purokivi und Riitta Kaarteenaho. „Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases“. PLOS ONE 15, Nr. 11 (30.11.2020): e0242860. http://dx.doi.org/10.1371/journal.pone.0242860.
Der volle Inhalt der QuelleBanuls, Lorrain, Juliette Vanoverschelde, Fanny Garnier, Matthieu Amalric, Samir Jaber, Jonathan Charbit, Kevin Chalard et al. „Interstitial Lung Disease Worsens Short- and Long-Term Outcomes of Systemic Rheumatic Disease Patients Admitted to the ICU: A Multicenter Study“. Journal of Clinical Medicine 10, Nr. 5 (03.03.2021): 1037. http://dx.doi.org/10.3390/jcm10051037.
Der volle Inhalt der Quellevon der Beck, Daniel, Friedrich Grimminger, Werner Seeger, Andreas Günther und Benjamin Löh. „Interstitial Lung Disease: Seasonality of Hospitalizations and In-Hospital Mortality 2005–2015“. Respiration 101, Nr. 3 (08.10.2021): 253–61. http://dx.doi.org/10.1159/000519214.
Der volle Inhalt der QuelleAnwar, Khadeeja, Ummara Siddique, Irfanullah Khan, Abdullah Safi, Hadia Abid, Ayesha Anwar und Karishma Israr. „Diagnostic Accuracy of Chest X-Ray in Interstitial Lung Diseases, Keeping High Resolution Computed Tomography Scan as Gold Standard“. Journal of Gandhara Medical and Dental Science 11, Nr. 1 (31.12.2023): 64–67. http://dx.doi.org/10.37762/jgmds.11-1.559.
Der volle Inhalt der QuelleSuda, Takafumi. „Up-to-Date Information on Rheumatoid Arthritis-Associated Interstitial Lung Disease“. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 9s1 (Januar 2015): CCRPM.S23289. http://dx.doi.org/10.4137/ccrpm.s23289.
Der volle Inhalt der QuelleIzuka, S., H. Yamashita, Y. Takahashi und H. Kaneko. „SAT0040 RISK FACTORS FOR DEVELOPING AND MORTALITY FOR ACUTE EXACERBATION OF RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE“. Annals of the Rheumatic Diseases 79, Suppl 1 (Juni 2020): 950.2–951. http://dx.doi.org/10.1136/annrheumdis-2020-eular.411.
Der volle Inhalt der QuelleKershaw, Corey D., Kiran Batra, Jose R. Torrealba und Lance S. Terada. „Characteristics and evaluation of acute exacerbations in chronic interstitial lung diseases“. Respiratory Medicine 183 (Juli 2021): 106400. http://dx.doi.org/10.1016/j.rmed.2021.106400.
Der volle Inhalt der QuelleYasuda, Yuto, Takashi Nomizo, Hiroaki Ozasa, Tomoko Funazo, Takahiro Tsuji, Hironori Yoshida, Yuichi Sakamori et al. „Retrospective analysis of acute exacerbation of interstitial lung diseases with nanoparticle albumin-bound paclitaxel in patients with advanced lung cancer with preexisting interstitial lung disease“. Molecular and Clinical Oncology 7, Nr. 4 (11.08.2017): 677–80. http://dx.doi.org/10.3892/mco.2017.1373.
Der volle Inhalt der QuelleCano-Jiménez, Esteban, Fernanda Hernández González und Guadalupe Peloche. „Comorbidities and Complications in Idiopathic Pulmonary Fibrosis“. Medical Sciences 6, Nr. 3 (30.08.2018): 71. http://dx.doi.org/10.3390/medsci6030071.
Der volle Inhalt der QuelleManfredi, Andreina, Marco Sebastiani, Stefania Cerri, Caterina Vacchi, Roberto Tonelli, Giovanni Della Casa, Giulia Cassone et al. „Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature“. Journal of Thoracic Disease 11, Nr. 4 (April 2019): 1621–28. http://dx.doi.org/10.21037/jtd.2019.03.28.
Der volle Inhalt der QuelleKorolev, A. M. „Blood changes in chronic nonspecific lung diseases under the influence of hemotherapy“. Kazan medical journal 50, Nr. 4 (31.03.2022): 67. http://dx.doi.org/10.17816/kazmj101353.
Der volle Inhalt der QuelleKimura, Toru, Takashi Nojiri, Hiroshi Hosoda, Yasushi Shintani, Masayoshi Inoue, Mikiya Miyazato, Meinoshin Okumura und Kenji Kangawa. „Exacerbation of bleomycin-induced injury by lipopolysaccharide in mice: establishment of a mouse model for acute exacerbation of interstitial lung diseases“. European Journal of Cardio-Thoracic Surgery 48, Nr. 4 (29.07.2015): e85-e91. http://dx.doi.org/10.1093/ejcts/ezv261.
Der volle Inhalt der QuelleLee, Jae Ha, Ji Hoon Jang, Jin Han Park, Hang-Jea Jang, Chan Sun Park, Sunggun Lee, Seong-Ho Kim, Ji Yeon Kim und Hyun Kuk Kim. „The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases“. PLOS ONE 16, Nr. 7 (27.07.2021): e0255365. http://dx.doi.org/10.1371/journal.pone.0255365.
Der volle Inhalt der QuelleBeghé, Bianca, Stefania Cerri, Leonardo M. Fabbri und Alessandro Marchioni. „COPD, Pulmonary Fibrosis and ILAs in Aging Smokers: The Paradox of Striking Different Responses to the Major Risk Factors“. International Journal of Molecular Sciences 22, Nr. 17 (27.08.2021): 9292. http://dx.doi.org/10.3390/ijms22179292.
Der volle Inhalt der QuelleYamakawa, Hideaki, Takashi Ogura, Hideto Kameda, Tomoo Kishaba, Tae Iwasawa, Tamiko Takemura und Kazuyoshi Kuwano. „Decision-Making Strategy for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD)“. Journal of Clinical Medicine 10, Nr. 17 (25.08.2021): 3806. http://dx.doi.org/10.3390/jcm10173806.
Der volle Inhalt der QuelleRicci, Alberto, Alessandra Pagliuca, Morgana Vermi, Dario Pizzirusso, Marta Innammorato, Raffaele Sglavo, Francesco Scarso et al. „The Role of Lung Colonization in Connective Tissue Disease-Associated Interstitial Lung Disease“. Microorganisms 9, Nr. 5 (27.04.2021): 932. http://dx.doi.org/10.3390/microorganisms9050932.
Der volle Inhalt der QuelleNakashima, Kazuki, Toyoshi Yanagihara, Sae Ishida, Naruhiko Ogo, Ayaka Egashira, Tatsuma Asoh und Takashige Maeyama. „Three cases of sequential treatment with nintedanib following pulsed-dose corticosteroids for acute exacerbation of interstitial lung diseases“. Respiratory Medicine Case Reports 33 (2021): 101385. http://dx.doi.org/10.1016/j.rmcr.2021.101385.
Der volle Inhalt der QuelleManfredi, Andreina, Marco Sebastiani, Stefania Cerri, Caterina Vacchi, Roberto Tonelli, Giovanni Della Casa, Giulia Cassone et al. „Erratum to acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature“. Journal of Thoracic Disease 12, Nr. 10 (Oktober 2020): 6411. http://dx.doi.org/10.21037/jtd-2020-64.
Der volle Inhalt der QuelleClement, Annick, Jacques de Blic, Ralph Epaud, Laurie Galeron, Nadia Nathan, Alice Hadchouel, Angelo Barbato et al. „Management of children with interstitial lung diseases: the difficult issue of acute exacerbations“. European Respiratory Journal 48, Nr. 6 (30.11.2016): 1559–63. http://dx.doi.org/10.1183/13993003.01900-2016.
Der volle Inhalt der QuelleRodrigues, Inês, Ricardo Estêvão Gomes, Lígia Maria Coutinho, Maria Teresa Rego, Firmino Machado, António Morais und Helder Novais Bastos. „Diagnostic yield and safety of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases: a systematic review and meta-analysis“. European Respiratory Review 31, Nr. 166 (05.10.2022): 210280. http://dx.doi.org/10.1183/16000617.0280-2021.
Der volle Inhalt der QuelleAraujo, Mariana Sponholz, Frederico Leon Arrabal Fernandes, Fernando Uliana Kay und Carlos Roberto Ribeiro Carvalho. „Pneumomediastinum, subcutaneous emphysema, and pneumothorax after a pulmonary function testing in a patient with bleomycin-induced interstitial pneumonitis“. Jornal Brasileiro de Pneumologia 39, Nr. 5 (September 2013): 613–19. http://dx.doi.org/10.1590/s1806-37132013000500012.
Der volle Inhalt der QuelleInotani, S., Y. Kondo, S. Takanashi, S. Ishigaki, S. Saito, M. Takeshita, J. Kikuchi, H. Hanaoka, K. Suzuki und Y. Kaneko. „POS1220 TRANSITION IN SYMPTOMS, ORGAN INVOLVEMENT, AND CLINICAL DIAGNOSIS OF PATIENTS POSITIVE FOR ANTI-ARS ANTIBODIES“. Annals of the Rheumatic Diseases 82, Suppl 1 (30.05.2023): 945.1–945. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1345.
Der volle Inhalt der Quellevan den Bosch, Laura, Fabrizio Luppi, Giovanni Ferrara und Marco Mura. „Immunomodulatory treatment of interstitial lung disease“. Therapeutic Advances in Respiratory Disease 16 (Januar 2022): 175346662211170. http://dx.doi.org/10.1177/17534666221117002.
Der volle Inhalt der QuelleTandjaoui-Lambiotte, Y., F. Gonzalez, M. Boubaya, O. Freynet, C. Clec´h, N. Bonnet, G. Van Der Meersch et al. „Two-year follow-up of 196 interstitial lung disease patients after ICU stay“. International Journal of Tuberculosis and Lung Disease 25, Nr. 3 (01.03.2021): 199–205. http://dx.doi.org/10.5588/ijtld.20.0706.
Der volle Inhalt der QuelleLaneri, Alessia, Stefania Cerri, Giovanni Della Casa, Antonio Moretti, Andreina Manfredi, Marco Sebastiani, Enrico Clini und Carlo Salvarani. „COVID-19, A New Possible Mimicker of Interstitial Lung Disease Related to Primary Sjögren’s Syndrome“. Case Reports in Medicine 2023 (09.12.2023): 1–6. http://dx.doi.org/10.1155/2023/9915553.
Der volle Inhalt der QuelleHan, Ji-yeon, und Jae Ha Lee. „Application and Interpretation of High-Resolution Computed Tomography for the Diagnosis of Interstitial Lung Disease (ILD): ILD Protocol“. Korean Journal of Medicine 98, Nr. 6 (01.12.2023): 294–99. http://dx.doi.org/10.3904/kjm.2023.98.6.294.
Der volle Inhalt der QuelleSharma, Neha, Chandran Nagaraj, Bence M. Nagy, Leigh M. Marsh, Natalie Bordag, Diana Zabini, Malgorzata Wygrecka et al. „RGS5 Determines Neutrophil Migration in the Acute Inflammatory Phase of Bleomycin-Induced Lung Injury“. International Journal of Molecular Sciences 22, Nr. 17 (28.08.2021): 9342. http://dx.doi.org/10.3390/ijms22179342.
Der volle Inhalt der Quelle